Treatment for Hemophilia B

On December tenth, Britain researchers  have treated six patients infected by the disease, hemophilia B.  This disease affected most royal houses throughout Europe but is also the first disease to be treated by gene therapy.  Gene therapy has not had many successes with rare diseases i.e., cancer causing or death.  Gene therapy consists of replacing the defective gene in any genetic disease with the intact version.  Researchers have made improvements to this procedure to treat Hemophilia B.  The small amounts injected into the patient’s veins produces small amounts of Factor IX, which is the area where Hemophilia clots.  Hemophilia A disease has yet to have success in gene therapy because of Factor VIII larger size.